Fig. 7: Orthogonal validation of FGFR1 mediated regulation of MYC-EZH2-CDKN1C axis- in MCL.

A Western blots showing expression of p-Erk1/2, MYC, p-Rb, EZH2, KDM2B, and CDKN1C upon erdafitinib treatment of 3 MCL Patient-derived xenografts ex-vivo. B Tukey plots showing FGFR1, CDKN1C, TUBA1B, CDK1, UHRF1, and PCNA expression in 20 MCL patients compared to healthy donor B-cells. C Model showing the role of FGFR1 regulating feedback loop in MCL.